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9 Abstract
10 Mechanisms underlying the in vitro cytotoxicity of Polyamidoamine nano-dendrimers in human keratinocytes are explored. Previous
11 studies demonstrated a systematic, dendrimer-generation-dependent cytotoxicity, oxidative stress, and genotoxicity. The emerging picture is
12 of dendrimer endocytosis, endosomal rupture and subsequent mitochondrial attack and cell death. To understand the underlying mechanisms,
13 the evolution of reactive oxygen species, intracellular glutathione, caspase activation, mitochondrial membrane potential decay, and
14 inflammatory responses have been examined. Early-stage responses are associated with endosomal encapsulation, later-stage with
15 mitochondrial attack. In all cases, the magnitude and evolution of responses depend on dendrimer generation and dose. The early-stage
16 response is modelled using a rate equation approach, qualitatively reproducing the time, dose and generation dependences, using only two
17 variable parameters. The dependence of the response on the nanoparticle physicochemical properties can thus be separated from internal
18 cellular parameters, and responses can be quantified in terms of rate constants rather than commonly employed effective concentrations.
19 © 2012 Elsevier Inc. All rights reserved.
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21
22 The rapid advance of nanotechnology has rendered it
23 imperative that possible hazardous effects of nanomaterials on
24 humans and the environment are elucidated. Nanoparticles (NPs)
25 with different chemical composition and size have been shown to
26 induce different levels of injury to cells and organisms, and thus
27 a fundamental understanding of the mechanisms of their
28 interaction is critical.1 In vitro studies have demonstrated that
29 the generation of intracellular reactive oxygen species (ROS) by
30 NPs is a key to their toxicity by triggering different cell-death
31 pathways, including cytokine2 and caspase-activation3 and
32 nuclear-DNA damage.4
33 To elucidate the mechanisms underlying toxic responses and
34 establish structure-activity-relationships, NPs of well-defined
35 physicochemical properties that are systematically variable and
36 elicit systematically variable cellular responses can play a key
37 role. PAMAM dendrimers are widely explored, commercially
38 available NPs of well-defined structure.5-9 They have a 2-carbon
39 ethylenediamine core with terminal amidoamines attached,
40yielding a highly branched radial structure having tertiary-
41amine branches and primary surface amino-groups. The diameter
42and number of surface amino-groups increases systematically
43with increasing generation.5
44PAMAM dendrimers have been proposed for a range of
45biomedical applications, from MRI contrast agents,10 to targeted
46delivery of drugs,11 DNA,12 and siRNA,14 However, they have
47been reported to be toxic to mammalian cell lines5-9 and aquatic
48species.7 The polar surface amino groups impart an effective
49cationic charge, and endocytosis leads to oxidative-stress,
50mitochondrial and DNA damage, and ultimately apoptosis.5-9
51PAMAM dendrimers have also been reported to activate
52expression of different cytokines, such as tumor necrosis factor
53(TNF-α), interleukin-6 (IL-6), and macrophage inflammatory
54protein-2 (MIP-2), in a mouse macrophage cell line.8 Previous
55studies have demonstrated the cytotoxicological responses to
56these species to vary systematically with increasing dendrimer
57generation and therefore number of surface amino groups.5,6,8 A
58similar systematic response was observed for the generation of
59ROS, onset of apoptosis, and levels of DNA damage.6 The
60mechanism of the toxic response has been at least partially
61elucidated, based on standard cytotoxicity assays including
62MTT, AB, and NR and microscopic co-localization studies.6,15
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63 The mechanistic model which has emerged is one of
64 endocytosis, oxidative stress, endosomal rupture through the
65 proton-sponge effect, followed by mitochondrial damage and the
66 onset of apoptosis.6,16 The use of amine groups to induce
67 endosomolytic behavior is a well-established strategy in drug
68 delivery,17 and the endosomolytic activity observed for
69 PAMAM dendrimers is consistent with this. The cellular toxicity
70 thus has primarily two phases; an early-stage, in which oxidative
71 stress is primarily due to the presence of particles in endosomes,
72 and a later stage, in which the particles migrate to the
73 mitochondria, generating further oxidative-stress.6,9 However,
74 the toxicity of a specific NP to different cell lines can differ, due
75 to the differences in intracellular constituent levels.6 Under-
76 standing the metabolic pathways in the target cell, and their dose
77 and time dependencies, is therefore critical to understanding the
78 toxic responses in vitro, and ultimately in vivo.
79 In this study, the mechanism of PAMAM toxicity to the
80 human keratinocyte, HaCaT, cell line is further explored. ROS
81 production upon exposure to different PAMAM generations and
82 doses is monitored as a function of time. Intracellular levels of
83 the antioxidant glutathione (GSH), representative of the natural
84 cellular antioxidant defense mechanisms, are also monitored.
85 Changes in caspase-8 and caspase-3 activity, mitochondrial
86 membrane potential (MMP) and TNF-α, IL-8 expression, over
87 an exposure period of 24 hours are also explored. Based on the
88 observations, potential underlying pathways for the early- and
89 late-stage cellular responses are proposed.
90 The early-stage responses are visualized with the aid of a
91 phenomenological rate-equation model, which qualitatively
92 reproduces the generation and dose dependence of the sequence
93 of events. It is highlighted that, although simplistic, such a rate-
94 equation approach is a valuable tool in visualizing and
95 elucidating cellular responses. It identifies response rates as
96 critical parameters in determining toxicity and potentially a more
97 reliable route towards quantitative structure-activity relation-
98 ships than commonly employed cytotoxicological endpoints.
99 Methods
100 Commercially available PAMAM dendrimers of generation
101 4 (G4), 5 (G5) and 6 (G6) were used in this study. The
102 nominal diameters of the PAMAM G4, G5, and G6 dendrimers
103 are 4.5, 5.4, and 6.7 nm respectively.5 Full physicochemical
104 characterization has been reported.5 All studies were performed
105 using HaCaT cells. Assays were performed to evaluate ROS
106 generation, GSH depletion, caspase-8 and 3 activation,
107 mitochondrial membrane potential decay (MMPD), and TNF-
108 α and IL-8 expression upon PAMAM exposure at different
109 doses and time points. A detailed description of the materials
110 used and experimental methods is given in the Supplementary
111 Material available online at http://www.nanomedjournal.com.
112 Experimental results
113 ROS measurement
114 The generation of ROS shows a complex behavior as a
115 function of time and dose for all PAMAM dendrimer
116 generations, although the response is somewhat systematic as
117a function of generation. As a function of exposure time, a
118biphasic response is observed over a 24-hour time period at
119lower concentrations of PAMAM, as shown in Figure S1. At a
120fixed time point, the increase in ROS levels has been shown to
121increase monotonically with generation (Figure S1, C),8 and
122when expressed in terms of molar concentration of surface NH2
123groups, the dose dependences of ROS for the different
124generations are overlaid.13
125For PAMAM G6, an initial or early-stage maximum in
126ROS levels is observed after ~1 hour, for doses of 0.5 μM to
1271.16 μM, whereas for higher doses (1.3 μM and 2.23 μM), the
128maximum is observed at ~0.5-hour exposure (Figure 1, A). At
129~ 4 hours, exposure at all concentrations results in a reduction of
130the ROS levels below those of the control, whereas a later
131increase in the ROS levels is observed at ~24 hours for doses of
1320.5 μM and 1 μM.
133A similar behavior is observed for exposure to PAMAM G5,
134although the early-stage maximum for the lower doses has
135shifted toward the longer time of ~2 hours (Figure S1, A). This
136trend is continued for G4, all but the highest exposure
137concentration exhibiting a maximum response after ~3 hours
138(Figure S1, B). After ~24 hours, only the lowest dose exposure
139results in ROS levels above the control, all others being
140significantly quenched in comparison with the control levels.
141At a concentration of 1μM, the maximum amount of ROS
142was produced after a ~ 24-hour exposure, the levels increasing
143with increasing generation of PAMAM (G4bG5bG6). Notably,
144this concentration is close to the EC50 of G5 and G6, as
145previously determined in HaCaT cells using MTT assay (Table
146S1), and at this concentration, increased lysosomal activity in
147comparison with control after ~24-hour exposure was also
148observed.6 It was found that, at this concentration, in early stages
149after exposure (e.g., 1 hour), ROS levels increased linearly with
150number of surface amino groups per generation, as shown in
151Figure S1, C. With increasing doses, for all generations, after
152initial increase in ROS levels, the levels are seen to be reduced
153significantly below those of negative controls and do not recover
154over a 4-hour period.
155ROS localization by CFM
156Confocal fluorescence microscopy (CFM) demonstrates
157that early-increased (1 – 2 hour) levels of ROS localized in
158sacs/vesicles in cytosol (Figure S2, A), consistent with previous
159observations of early-stage trafficking of endocytosed PAMAM
160dendrimers in endosomes.15 However, in the later stages
161(~24 hours), ROS are co-localized in the mitochondria (Figure
162S2, B), potentially indicating that they are generated through
163differing mechanisms.
164GSH measurement
165In control cells, intracellular GSH level increases approxi-
166mately linearly as a function of time over 24 hours, as shown in
167Figure 1, B. Such a linear increase is commonly observed when
168studying in vitro cell cultures.18,19 Upon exposure to PAMAM
169dendrimer solutions at a 1-μM concentration, initial linear
170increase in GSH levels follows the trend observed for control,
171but an abrupt deviation from the levels of controls is observed
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172 within 1 – 5 hours. For G4, the deviation is observed after 4
173 hours, for G5 3 hours, and for G6 1 hour. Following these
174 timepoints, the degree of reduction of the GSH levels is also seen
175 to be systematic in dendrimer generation (G4bG5bG6).
176Caspase-8 and -3 activity
177The activity of caspase-8 and 3 was studied at different time
178points for 1-μM doses of PAMAMG4, G5, and G6. For both the
179caspases, a biphasic activity was observed (Figure 2). For
180PAMAM G4 and G5, an initial or early-stage maximum of
181caspase-8 levels was observed after ~4 hours’ exposure,
182whereupon a minimum was observed before subsequent increase
183after 24 hours’ exposure (Figure S3, A, S3, B). For G6, the early-
184stage maximum was found after ~2 hours’ exposure (Figure
185S3C). Comparing the percentage increase of caspase-8 with
186control upon exposure to 1 μM for the different PAMAM
187generations after 24 hours, a systematic increase is observed
188(G4bG5bG6).
189A similar behavior is observed for the time evolution of
190caspase-3 levels. For PAMAM G4 and G5, early-stage
191maximum were observed at ~4 hours’ exposure and after an
192intermediate decrease, a late increase of caspase-3 activity was
193observed at 24 hours (Figure-S3, A, S3, B). For G6, early-stage
194increase of caspase-3 activity was observed at ~2 hours’
195exposure (Figure S3, C). Again, a systematic generation
196dependence of the percentage increase of caspase-3 levels in
Figure 1. (A) ROS generation in HaCaT cells upon different concentrations
of PAMAM G6 exposure. (B) GSH depletion upon 1 μM PAMAM G4, G5,
G6 exposure in HaCaT cells as a function of exposure time. The y-axis shows
the fluorescence intensity of the ThiolTracker Violet dye measured in the
plate reader. The values are represented as arbitrary units (arb. units). (C)
Mitochondrial membrane potential decay of HaCaT cells as a function of
exposure time to 1 μM of PAMAM G4, G5, and G6.
Figure 2. Expression of different caspases after exposure times of 1 μM
PAMAM G4, G5 and G6- (A) caspase-8, (B) caspase-3.
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197 comparison with control upon 1-μM exposure after 24 hours is
198 observed (G4bG5bG6). Thus, although, in a similar way to the
199 behaviour of ROS levels, the temporal evolution is complex, a
200 clear systematic variation in the response with dendrimer
201 generation is also evident.
202 Mitochondrial membrane potential decay
203 Upon exposure to 1-μM solutions of the respective PAMAM
204 dendrimer generations over a 24-hour period, the percentage of
205 mitochondrial membrane potential decay (MMPD), in compar-
206 ison with controls, also shows a biphasic response, as shown in
207 Figure 1, C. For all generations, the degree of MMPD increases
208 initially within early stages of exposure. It then decreases to a
209 minimum after ~ 6 – 7 hours of exposure, after which a further
210 increase is observed up to 24 hours of exposure. The early-stage
211 MMPD was observed after ~ 4 – 5 hours for G4 and ~ 2 – 3
212 hours for G5 and G6. At all time points, percentage of MMPD in
213 comparison with control was seen to vary systematically with
214 dendrimer generation (G4bG5bG6).
215 TNF-α and IL8 expression
216 An upregulation of TNF-α expression that is time, dose, and
217 generation dependent was observed. For G4, the maximum
218 amount of TNF-α was expressed at a concentration of 3.21 μM
219 after ~6-hour exposure, as shown in Figure S4, A. For G5, the
220 maximum amount of TNF-α expression was observed for 1 μM
221 after ~ 4-hour exposure (Figure S4, B). For G6, the maximum
222 amount of TNF-α is expressed at 1 μM after ~4-hour exposure
223 (Figure S4, C). For a 1-μM dose, maximum percentage of TNF-
224 α expression in comparison with the controls increases with
225 increasing PAMAM generation (G4bG5bG6), although the
226 maxima occur at different exposure times (Figure 3, A).
227 Over a 24-hour period, IL-8 expression shows a monotonic-
228 increase for all doses, for all dendrimer generations, and the
229 maximum response was observed after a 24-hour exposure. For
230 G4, the maximum amount of IL-8 was expressed at 3.21 μM
231 (Figure S5, A), for G5, at 1μM (Figure S5, B) and for G6 at 1 μM
232 (Figure S5, C). The percentage of IL-8 expression in comparison
233 with controls increases with increasing generation of PAMAM
234 (G4bG5bG6), as shown for 1-μM dose in Figure 3, B.
235 Discussion and numerical simulation
236 The cellular responses upon exposure to PAMAM dendri-
237 mers are a complex function of generation, dose, and time.
238 Figure 4 summarizes the time evolution of the cellular responses
239 for the case of 1-μM exposure to the G6 dendrimer. The plot
240 indicates a defined sequence of events, and the relative temporal
241 evolutions of the different responses indicate some degree of
242 interdependence of the responses.
243 Previous studies have demonstrated a two-phase response of
244 cells to exposure to PAMAM dendrimers; early-stage localiza-
245 tion in endosomes,15 followed by a later-stage localization in
246 mitochondria.9 These two phases are well visualized in Figure
247 S2, A and S2, B, whereby, at early stages, the ROS are primarily
248 localized in smaller vesicles assumed to be endosomes, whereas
249after 24 hours, the ROS are mostly localized in the mitochondria.
250This two-stage process is further manifest in the time-dependent
251profile of the ROS levels at low doses, for all generations, as
252shown in Figure 1, A.
253Key to the onset of the toxic response is the increase in ROS
254levels upon PAMAM exposure and the concomitant changes in
255intrinsic cellular antioxidant levels. As shown in Figure 1, B, a
256linear increase in cellular GSH levels is observed in control cells.
257Upon exposure to PAMAM dendrimers, a generation-dependent
258reduction in the rate of increase of GSH levels is observed. The
259degree and rate of reduction is generation dependent, associating
260the phenomenon with early-stage increase of ROS levels as a
261result of exposure.20 It should be noted, upon careful inspection,
262that there is an apparent time lag between the onset of ROS and
263the deviation of the GSH levels from linearity. This lag is
264understandable in terms of differing experimental protocols used
265to monitor the respective responses. To monitor ROS levels,
266carboxy-H2DCFDA dye was uploaded in the cells before particle
267exposure, whereupon ROS levels were measured after different
268exposure times. For the measurement of TNF-α, IL-8, and
269caspases, the cells were lysed immediately after exposure and so
270the exposure time was equal to the measurement time. To
271monitor GSH levels, however, cells were stained with
272ThiolTrackerTM Violet for a period of ~30 minutes post
Figure 3. Inflammatory responses in HaCaT cells upon 1-μM exposures to all
dendrimer generations for different time points (A) TNF-α, (B) IL-8.
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273 exposure. Thus, including sample washing and preparation, there
274 is a gap of 30 – 60 minutes from exposure time.
275 Although the results indicate systematic dependences of
276 responses on dose and dendrimer generation, the four-dimen-
277 sional response/dose/time/generation system is not easily
278 visualized. To better visualize and elucidate the mechanisms of
279 response, the system can be modeled using a simple phenom-
280 enological rate-equation model, similar to those commonly
281 employed for modeling molecular photodynamics.21 The
282 particle dose and levels of ROS, GSH, etc., are described by
283 populations, and changes in populations are governed by rate
284 constants. The rate equations can be numerically integrated using
285 an iterative Euler approach22 to yield the temporal evolutions of
286 the populations.
287 Salvati et al have demonstrated that the cellular uptake of
288 polystyrene NPs occurs by endocytosis at a constant rate over a
289 time period of 24 hours and that the rate is dose dependent.23 In
290 the case of PAMAM dendrimers, endocytotic process is assumed
291 to be generation dependent, and thus the number of particles in
292 the cells, N, increases as:
dN
dt
= GKendoD Equation 1
2934 where Kendo is an endocytosis rate constant, G is a generation-
295 dependent scaling factor, and D represents the dose. Once
296 endocytosed, particles continuously generate ROS, build-up of
297 ROS is counteracted by increased levels of GSH, and the
298 interaction quenches both the levels of ROS and GSH. Thus:
dNROS
dt
= NGKROS−KqNROSNGSH Equation 2
299300dNGSH
dt
= KGSH−KqNROSNGSH Equation 3
3012303The first term in Equation 2 is a generation- (G) and dose-
304(D) dependent term describing continuous ROS generation at
305a rate KROS. This rate is independent of dendrimer generation,
306but DKROSG scales linearly with the number of surface
307amino groups per generation and dose. The second term
308describes the quenching of the ROS at a rate Kq, which
309depends on both ROS levels, NROS, and GSH levels, NGSH. In
310Equation 3, the linear increase of the control levels of GSH, at
311a rate of KGSH, is described by the first term, and the second
312term describes the quenching of the GSH levels. Thus, as a
313function of generation, for the same molar concentration,
314simply changing the parameter G for successive generations
315should reproduce the generation-dependent behaviors observed
316in Figures 1, A and 1, B, and, for a given dendrimer generation,
317changing D should similarly mimic the dose dependences of
318Figure 1, A.
319Using a constant generation rate, however, the model predicts
320a monotonic increase in ROS levels over the exposure time, in
321contrast to early increase and decrease observed experimentally.
322If, however, the ROS population is constrained to saturate, a
323generation- and dose-dependent rise and fall is reproduced. To
324simulate such saturation, the rate of generation is proposed to
325be dependent on the number of ROS generated and thus time
326such that:
dKROS
dt
= −KROSNROS Equation 4
3278329Figure 5, A shows the predicted time and generation
330dependence of the rate of generation of ROS. Based on such a
331saturable ROS generation rate, Figure 5, B and 5, C show the
Figure 4. Representation of the different cellular responses as a function of time, for 1-μM exposure to PAMAM G6. For visual purposes, the responses from
different assays have been normalized to 1 and different responses are offset by 1. The normalized responses are all in respect of negative controls, whereby the
response for ROS represents percentage of ROS generation in comparison with control, GSH represents percentage of depletion in comparison with control;
caspase-8, caspase- 3, TNF-α, and IL-8 represent percentage of expression in comparison with control; mitochondrial membrane potential decay represents
percentage of MMPD in comparison with control.
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332 simulated behaviors for the levels of intracellular ROS and GSH
333 as a function of generation. For G4, maximum ROS levels
334 are observed at ~3 hours, for G5 at ~2 hours, and for G6 at
335 ~1.6 hours, in good agreement with experimental observations.
336 Notably, however, the evolution curves of Figure 5, B are not
337 as sharply varying with time as the behaviors observed
338 experimentally in Figure 1, A. This is a result of the simplistic
339 representation of the rate of generation of ROS in Equations (2-
340 4). This is further manifest in the smooth departure of the levels
341of GSH from linearity in Figure 5, C, in comparison with rather
342abrupt behavior observed in Figure 1, B. The time delay between
343experimental ROS and GSH generation observed by comparing
344Figures 1, A and 1, B is further manifest here, as the modeled
345GSH follows the modeled increase in ROS levels. Because of the
346complexity of multiple processes leading to ROS generation and
347saturation, the simulation cannot therefore be considered to be a
348fit to Q2the experimental data. Nevertheless, the simplistic approach
349qualitatively reproduces generation-dependent departure from
350linearity of the GSH levels in both extent and rate.
351The simulations similarly faithfully predict an approximately
352linear dependence of the relative amounts of ROS on generation
353number, and therefore on number of surface amino groups for a
354fixed time and dose, as shown in Figure S6, A for the case of 1
355hour of exposure of G6. At the 6-hour time point, however, a
356notably different behavior is observed, highlighting the impor-
357tance of experimentally monitoring the full-time evolution of the
358response. Moreover, as the maxima shift in time as a function of
359dose and generation, at specific time points, complex dose
360dependences similar to those in Figure 1, A, can be reproduced,
361as shown in Figure S6, B for the cases of 1 hour, 1.5 hours and 2
362hours of G6 exposure.
363It should be noted that biphasic ROS generation is observed
364only at low doses in a generation-dependent fashion. At
365elevated doses, the levels of GSH are depleted such that the
366ROS levels are not quenched and no intermediate time-scale
367minimum in their levels is observed. In Figure 5, C, the
368generation dependence of this process is apparent in the
369prolonged timescales of GSH depletion, which further increase
370with increasing dose.
371The activities of both caspase-8 and 3 upon 1-μM PAMAM
372exposure were also found to be biphasic over 24 hours for all
373generations (Figures 2, S3). The maximum percentages of early
374caspase-8 were activated after ~4 hours’ exposure of G4 and G5,
375whereas those for G6 occurred after ~2 hours’ exposure
376(Figure 2, A). The activity then decreased to, or below, the
377level of the control after ~12 hours for G4 and G5 and after ~6
378hours for G6, before subsequently increasing to a maximum after
37924 hours’ exposure (Figure 2, A). Variations in activity of
380caspase-3 follow a trend similar to that of caspase-8 (Figure 2,
381B). In both cases, the activity profile and the percentage activity
382in comparison with control are dependent on generation.
383In an attempt to understand the possible underlying response
384pathways, it is noted that apoptosis can be mediated through
385two major pathways, the death-receptor pathway (extrinsic)24
386and the mitochondrial pathway (intrinsic).25 Notably, caspase-
3878 and 3 activations are seen to occur almost instantaneously
388after ROS generation, both in early and late stages. The
389observation of the early-stage maximum activation of caspase-
3908 before the maximum early-stage MMPD and activation of
391TNF-α indicates that caspase-8 activation in the current study
392is via the Fas/FasL mediated FADD pathway, independent of
393the TNF-α mediated FADD or mitochondrial pathway26
394(Figure 4). Previously it was also shown that intracellular
395ROS mediates Fas-ligation that leads to caspase-8 and 3
396activation.27 It is therefore proposed that activation of early
397caspase-8 and 3 is mediated via extrinsic FasL mediated
398Fas-signaling pathway.27,28 Caspase-8 activation acts as an
Figure 5. The simulated behaviors for all dendrimer generations of (A) the
rate of ROS generation, KROS, (B) the levels of intracellular ROS, and (C)
the levels of intracellular GSH as a function of time. In (C), the solid line
depicts the linear increase of GSH levels in negative controls.
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399 upstream process for caspase-3 activation by activating pro-
400 caspase-3.29 FADD pathway can be naturally inactivated by
401 caspase-8-like inhibitory protein (cFLIP)30,31 or can be inhibited
402 by the inhibitors of apoptosis proteins (IAPs), for example X-
403 linked inhibitor of apoptosis protein (XIAP).32,33 Such mecha-
404 nisms can potentially decrease the activity of caspase-8 and 3
405 after its early activation (Figures 2, S3).
406 The activation of caspase-8 by intrinsic mitochondrial
407 pathway, which is independent of the classical FADD pathway,
408 is also well known.34,35 Through this pathway, caspase-8 can be
409 activated either via mitochondrial p38-MAPK or mitogen- and
410 stress-response kinase 1 (MSK1), which are sequentially
411 activated upon mitochondrial oxidative-stress (Mchichi et al,
412 2007). The second-phase of caspase-activation follows the
413 second-phase of ROS, generated in the mitochondria, thereby
414 causing mitochondrial oxidative-stress. Therefore, its activation
415 could potentially occur through the mitochondrial p38-MAPK or
416 MSK1 pathway.
417 The expression of TNF-α, a pro-inflammatory cytokine, can
418 also be activated by p38-MAPK and other MAPKs upon
419 oxidative stress.36 NPs have been shown to upregulate TNF-α
420 and CXCL8 via ROS and MAPK activation.37 TNF-α activation
421 in turn activates the expression of the chemokine IL8.38 It has
422 also been reported that TNF-α downregulates FasL expression in
423 the vascular endothelial cells.39 Therefore, sequential TNF-α
424 and IL8 expressions following early-stage maximum in ROS
425 generation caspase activation, and MMPD is consistent with its
426 activation by a MAPK pathway. TNF-α activation before the
427 second-phase of caspase activation possibly activates Smac/
428 Diablo, which inhibit IAPs,40 resulting in the second phase of
429 caspase activity with prolonged exposure time.
430 The mitochondrial membrane potential study reveals that the
431 decay rapidly follows the caspase activation, in both early and
432 later stages, with a delay of ~ 45 minutes to 1 hour (Figures 2 and
433 1, C). This delay comes in part from the staining of the cells with
434 rhodamine-123 for measuring mitochondrial membrane potential
435 after the exposure time point, whereas in caspase study the cells
436 were lysed immediately after exposure. Therefore, caspase
437 activation, which is an instantaneous effect of ROS generation,
438 probably via Fas pathway, results in rapid decay of MMP.28 The
439 extent of MMPD and the time evolution is generation dependent
440 (Figure 1, C). The biphasic response is consistent with the model
441 of early-stage ROS generation by particles in subcellular
442 vesicles, most likely endosomes, which cause oxidative stress
443 to the mitochondria, followed by endosomal release and
444 localization of the dendrimer particles in the mitochondria,
445 leading to cell death via the mitochondrial injury pathway,41
446 generating further ROS as a result.41,9 The decrease in MMPD
447 after the early-stage increase could be due to the effects of
448 mitochondrial chaperones, e.g., prohibitin, which elevate the
449 synthesis of ATP and stabilize MMP, delaying the onset of
450 apoptosis.42
451 The inflammatory study indicates a subsequent sequential
452 activation of TNF-α and IL-8. The maximum TNF-α
453 expression was observed after ~6 hours’ exposure at 3.21 μM
454 for G4 and after ~4 hours’ exposure at 1 μM for G5 and G6
455 (Figure 3, A). Having reached the maximum, the expression is
456 seen to decrease with exposure time to levels less than control.
457The expression of IL-8 increases monotonically with exposure
458time to a maximum at 24 hours’ exposure at 3.21 μM for G4,
459and 1 μM for G5 and G6 (Figure 3, B). Above and below these
460concentrations, the expression of TNF-α and IL-8 decreases.
461Notably, these concentrations are also the EC50 values obtained
462from the dose response from MTT assay in HaCaT cells5
463(Table S1). The maximum percentage of increase of TNF-α
464and IL-8 expression was also seen to increase with increasing
465generation of PAMAM dendrimer, and therefore number of
466surface amino groups.
467It is notable that TNF-α activation is only observed in the
468early stages and does not follow the biphasic evolution of ROS
469and caspase activation and MMPD. In the early stages, the NPs
470are located in vesicles, proposed to be endosomes, and thus
471oxidative stress is generated external to the mitochondria. At the
472later stages, dendrimer NPs and generation of ROS have been
473located in the mitochondria.9,6 Although derived from the
474mitochondria, it has been demonstrated that acute, internal stress
475can suppress the expression of pro-inflammatory cytokines, such
476as TNF-α,43 without affecting IL-8 expression.44 Similarly,
477PAMAM generates acute stress when incorporated into
478mitochondria (24 hours)6 and the second phase of TNF-α
479expression is not observed in our study.
480In the first phase of evolution, the rate-equation model can be
481simply extended to include the ROS-dependent activation of
482caspases, and subsequent MMPD and generation of TNF-α and
483IL8, and thus visualize the generation and dose dependences,
484as described in the Supplementary Material. Figure 6, A–C
485illustrates the time evolution of the process as well as generation-
486dependent behavior predicted by the model, simply by changing
487the parameter G in Equations (1) and (2). All rates are kept
488constant and the differing rates of evolution of subsequent stages
489are the result of the early-stage generation- (or dose-) dependent
490increase in ROS levels. For example, maximum TNF-α
491expression is predicted for G4 at 5.1 hours, for G5 at 4.4 hours
492and for G6 at 4 hours. Although the experimental time intervals
493do not differentiate the maxima for G5 and G6, the model
494predicts a sequence of activation of G6bG5bG4. Furthermore,
495although the magnitudes of responses are normalized to the
496maximum for graphical representation, at each step in the
497cascade, the generation dependence of G6NG5NG4 is also
498reproduced faithfully, as shown by the approximately linear
499dependence of the maximum levels of TNF-α, as a function
500of number of surface amino-groups per dendrimer generation
501in Figure S7.
502In all cases, only the early stage of the cellular responses has
503been modeled. This stage is proposed to originate from initial
504endocytosis of the particles and encapsulation in endosomes.
505ROS is most likely generated via the proton-pump mechanism,
506resulting in depletion of GSH and other antioxidants and the
507onset of caspase activation, MMPD, and inflammatory re-
508sponses via TNF-α activation. The second phase appears to be
509spatially distinct, in that it is associated with localization of
510dendrimer NPs and ROS generation in the mitochondria.
511Although the second phase is not modeled here, a similar
512rate-equation approach could be employed to simulate the
513responses, their time evolution and dependences on dose and
514dendrimer generation. A more complete understanding of
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515 generation and dose dependence of the process of endosomal
516 rupture, particle migration to and uptake by the mitochondria,
517 and recovery of intracellular antioxidant levels would be
518 required. Between the two phases, such phenomena as the
519 quenching of ROS levels to below those of controls, the
520 recovery of antioxidant levels, and migration of antioxidants to
521 localised subcellular sites should be considered. Nevertheless,
522 the phenomenological model is readily adaptable to include
523 more complex phenomena, simply by adding additional terms to
524 the rate equations (Equation S1–S5).
525 The overall mechanism that can be postulated from the
526 cellular responses is diagrammatically represented in Figure S8.
527 PAMAM dendrimers enter the cells by endosomal uptake or by
528 rupture of the plasma membrane.15,6,45 Initial oxidative stress
529 results from early-stage ROS generation whereas the dendri-
530 mers are encapsulated in early-stage subcellular vesicles, most
531 likely endosomes.6 The generation dependence of the ROS
532 generation rate and yield point to the reactive NH2 surface
533 groups as the origin of oxidative stress. Intracellular antioxi-
534 dants result in a quenching of early-stage ROS and are
535themselves quenched by the action.46 The study of GSH levels
536and their time evolution, as an example of intracellular
537antioxidants, highlights the importance of intracellular defense
538mechanisms, and potentially points to a source of differentia-
539tion of different cellular responses to NP exposure. The ROS
540probably play a pivotal role in the possible FasL/Fas mediated
541activation of caspase-8 which further activates caspase-3,
542leading to the initial MMPD. Maximum TNF-α expression
543after early-stage maximum ROS, caspase-8 and 3 activities and
544MMPD suggests TNF-α activation by mitochondrial pathway.
545TNF-α subsequently induces IL-8 expression and therefore its
546expression gradually increases with exposure time. After
547reduction of early-stage ROS, it is proposed that the action of
548different caspase inhibitor proteins results in reduction of
549caspase-8 and 3 activities and MMP similarly recovers,
550possibly through the action of mitochondrial chaperones. In
551the second phase, PAMAM dendrimers rupture the endosomes
552by so-called “proton-sponge effect” and are released into the
553cytosol and interact directly with other cellular organelles. After
554~16 hours they have been located in the mitochondria,9
555whereupon the oxidative stress is increased, resulting in further
556MMPD. No further TNF-α expression is observed, but a
557second phase of activation of caspases is observed, which is
558possibly through the mitochondrial pathway. The sequential
559and potentially independent pathways of caspase activations
560that are associated with the early and late stage of ROS
561generation can be understood by further studies of the
562activation of Fas and mitochondrial p38MAPK or MSK1.
563The potential role of IAPs and cFLIP in the inhibition of
564caspase-8 and 3 after their early-stage activation and the
565contribution of Smac/Diablo activation profile should also be
566studied for further elucidation of the biphasic caspase
567activation. Following the activation of these different cell-
568death pathways and the activation of caspases, the cell enters
569apoptosis, its nuclear DNA undergoes fragmentation, and
570finally it dies.6
571Although simplistic at this stage, the numerical modeling
572approach enables a visualization of the complex generation, dose
573and time dependences of the cellular responses. A fundamental
574understanding of in vitro cytological responses is becoming
575increasingly important, given the implications of EU Directive
5762010/63/EU on reduction, replacement, and refinement of
577animal models for scientific experimentation. Consideration
578of the responses in terms of rate equations elucidates their
579sequence, interdependencies, and relative magnitudes. It is a
580potential route towards quantifying nanotoxicological responses
581in terms of response rates that are determined by NP properties
582and cellular and even cell-line-dependent parameters, indepen-
583dently. The overall cytotoxicological response, as frequently
584monitored by classic cytotoxicological assays and expressed, for
585example, as an EC50, is a convolution of a cascade of events,
586which can potentially be better expressed as response rates that
587can be defined per NP and cellular system.
588A nonlinear response and saturation are required to
589reproduce the experimental observations, but the origin and
590mathematical form of this nonlinearity and saturation requires
591clarification. In cytotoxicity, dose dependences are commonly
592empirically represented by the Hill function,47 but this is not
Figure 6. Illustration of the generation dependent behavior for (A) G4, (B)
G5, and (C)G6, in terms of normalized ROS generation, MMPD and TNF-α
and IL8 expression, predicted by the model, simply by changing the
parameter G in Equation (2).
8 S.P. Mukherjee, H.J. Byrne / Nanomedicine: Nanotechnology, Biology, and Medicine xx (2012) xxx–xxx
593 easily represented in a form that indicates the rates of
594 contributing processes.48 In pharmacokinetics, it is simply
595 acknowledged that to account for a nonlinear response to a
596 linear dose, at least one of the intermediate stages must be
597 nonlinear.49
598 The endocytotic process is assumed to be linearly dependent
599 on dose, but a low-dose exposure of many cells to few NPs is
600 most likely significantly different from one in which there are
601 many particles per cell, and ultimately the capacity of a single
602 cell to endocytose NPs must be limited. In the simplistic
603 treatment presented here, no changes to cell population due to
604 cell proliferation or death have been included. The doubling time
605 for HaCaT cells is 23 hours.50 The Alamar Blue assay shows
606 that, upon exposure to 1μM PAMAM G6 for 24 hours, the
607 percentage cytotoxicity in comparison with control was 28%
608 (data not shown). Therefore, it is predictable that after 6 hours’
609 exposure the effect of 1μM G6 on HaCaT cell proliferation and
610 viability was not significant.
611 Notably, the dose dependence of ROS generation is nonlinear
612 and potentially originates in its time evolution. However,
613 although the model demonstrates how a complex dose
614 dependence can arise, the results are by no means a fit with the
615 experimental data, and further work utilizing model NP systems
616 is required to accurately predict the dose dependence. Ultimate-
617 ly, however, such a rate-equation model may provide the basis
618 for quantification of NP toxicity and cellular susceptibility, and
619 thus quantitative structure-activity relationships.
620 Appendix A.Q3 Supplementary data
621 Supplementary data to this article can be found online at
622 http://dx.doi.org/10.1016/j.nano.2012.05.002.
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